On the recordJuly 10, 2018
340B is not the driver of high drug prices. The pharmaceutical corporations' unlimited power to set the list price is the driver.
Source
congress.gov340B is not the driver of high drug prices. The pharmaceutical corporations' unlimited power to set the list price is the driver.
Schakowsky argues that pharmaceutical companies, not the 340B program, are responsible for high drug prices.
Share
More from Janice Schakowsky
I am very concerned about income inequality in the United States, and Republicans have long claimed that cutting corporate taxes somehow is going to pay for itself.
We must expand Social Security benefits, not cut them, and I have a bill to do just that.
Donald Trump’s words, 'a whole civilization will die tonight, never to be brought back again,' are more than empty threats.